Mississippi 2025 Regular Session

Mississippi House Bill HB1119

Introduced
1/20/25  
Refer
1/20/25  

Caption

Pharmacy benefit managers; revise provisions related to.

Impact

By amending existing laws to strengthen the Pharmacy Benefit Prompt Pay Act, the legislation is expected to enhance the financial stability of pharmacies across the state. By mandating that PBMs cannot reimburse pharmacies at rates lower than NADAC and requiring prompt payments, HB1119 aims to create a more predictable revenue stream and improve cash flow for pharmacies, especially independent ones. Furthermore, the introduction of a reasonable administrative appeal process allows pharmacies to contest reimbursements they find unsatisfactory, potentially leading to more equitable treatment in reimbursement disputes. There is an emphasis on compliance and accountability, with penalties in place for non-compliance by PBMs.

Summary

House Bill 1119, known as the 'Representative Andy Stepp Pharmacy Benefit Prompt Pay Act', is designed to enhance the regulations surrounding pharmacy benefit managers (PBMs) in Mississippi. The bill aims to offer more stringent requirements for how PBMs handle reimbursements to pharmacies for prescription drugs, setting minimum reimbursement rates based on the National Average Drug Acquisition Cost (NADAC) and a professional dispensing fee aligned with Medicaid standards. This change seeks to ensure that pharmacies receive fair compensation and to prevent underpayment for the services they provide. Additionally, the bill restructures the process for PBMs regarding payment timelines, requiring claims to be paid within specified timeframes to lessen potential financial burdens on pharmacies.

Contention

Despite these intended benefits, there are notable concerns surrounding the legislation. Some stakeholders express apprehension that increased regulations on PBMs may lead to higher overall costs for healthcare plans and ultimately consumers. Critics fear that while the bill aims to protect pharmacies, it may inadvertently impose restrictions that could complicate the relationships between PBMs, pharmacies, and insurance providers. Furthermore, there is concern about the administrative burden on PBMs due to the new compliance requirements, which might impact their operational efficiencies and pricing strategies in the long term.

Companion Bills

No companion bills found.

Similar Bills

MS SB2677

Pharmacy Benefit Prompt Pay Act; define requirements for pharmacy benefit managers and pharmacy services administrative organizations.

MS HB1123

Pharmacy benefit managers and pharmacy services administrative organizations; provide certain regulations for.

MS HB1124

Pharmacy benefit managers; require to disclose certain information on rebates and contracts.

MS SB2678

Pharmacy Benefit Prompt Pay Act; bring forward and prohibit spread pricing.

MS HB1413

Pharmacy Benefit Manager Transparency Act; create.

MS HB856

Pharmacy Practice Act; extend repealer on and make various changes to.

MS SB2795

Pharmacy Practice Act; extend repealer on and make various changes in.

MS SB2675

Pharmacists; authorize to test for and administer treatment for minor, nonchronic health conditions.